Demetrix
PrivateLast Round
Series A
Jul 11, 2019
Total Funding Raised
$61M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Demetrix operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was a Series A round in July 2019.
Demetrix is a biotechnology company that developed a fermentation system to produce natural medicines and rare cannabinoids through genetics and computing-enabled technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Sustainable Materials
Business Model
B2B
Customer Profile
Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Demetrix Comparables
Compare Demetrix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Creo | 90% | |
| Hyasynth Biologicals Inc. | 90% | |
| Biomedican | 87% |
For institutional investors. Book with your work email.
Demetrix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 11, 2019 | ||||
| Seed | Sep 6, 2017 |
For institutional investors. Book with your work email.
Demetrix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A, Seed |
| Tuatara Capital | Series A |
| Berkeley Catalyst Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 190% MoM, reaching 1.2K.
- Aug 20, 2026
Monthly visitors grew 202% MoM.
For institutional investors. Book with your work email.
Demetrix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Demetrix's valuation, stock price, and market status.
Is Demetrix a public or private company?
Demetrix is a private company.
What is the current stock price of Demetrix?
Demetrix is a private company, so its shares have no public market price. Caplight tracks Demetrix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Demetrix worth (valuation)?
Valuation information for Demetrix is not publicly available.
Can I buy Demetrix stock?
Demetrix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Demetrix's last funding round?
Demetrix's most recent funding round was Series A on July 11, 2019.
Who are the main investors in Demetrix?
Key investors in Demetrix include Horizons Ventures, Tuatara Capital.
Will Demetrix IPO soon?
No public IPO plans have been announced for Demetrix.
How can I track Demetrix secondary market activity?
Caplight tracks bids, offers, and trades in Demetrix's shares on secondary markets.